Neuroscience
Investors ready to craft new biotechs out of Pfizer's discards
February 9, 2011 — 8:47am ET
By John Carroll
FierceBiotech
Read the article
- Preventing Surgical Nerve Damage
From FierceBiotech: Fluorescent peptides help nerves glow in surgery 08 February 2011 Read the press release...
- Fda Rejects Ezogabine
FDA rejects a new epilepsy drug from Valeant, GSK FierceBiotech 02 December 2010 Read FierceBiotech article here === Earlier blog post on topic, from 12th August: here ===...
- Business World: Gsk's Rare Diseases R&d Unit
From FierceBiotech: GSK launches new specialist unit to research and develop medicines for rare diseases Issued: Thursday 4 February 2010, London UK Read the full article...
- Fda Approves Multiple Sclerosis Drug, Ampyra (dalfampridine) Extended-release
From FierceBiotech: FDA approves Acorda's new MS drug January 22, 2010 — 4:49pm ET By John Carroll [snip] The FDA announced Friday afternoon that it has approved Ampyra (dalfampridine) extended-release tablets to improve walking in patients with...
- Merck's Cladribine And Multiple Sclerosis
From FierceBiotech: Merck KGaA pulls ahead in hot oral MS drug race By John Carroll September 11, 2009 — 8:22am ET Researchers for Merck KGaA say that new analysis of the late-stage data for their oral drug cladribine highlight the drug's potential...
Neuroscience
Will there be biotechs "emerging from the rubble at Sandwich"?
Investors ready to craft new biotechs out of Pfizer's discards
February 9, 2011 — 8:47am ET
By John Carroll
FierceBiotech
Read the article
- Preventing Surgical Nerve Damage
From FierceBiotech: Fluorescent peptides help nerves glow in surgery 08 February 2011 Read the press release...
- Fda Rejects Ezogabine
FDA rejects a new epilepsy drug from Valeant, GSK FierceBiotech 02 December 2010 Read FierceBiotech article here === Earlier blog post on topic, from 12th August: here ===...
- Business World: Gsk's Rare Diseases R&d Unit
From FierceBiotech: GSK launches new specialist unit to research and develop medicines for rare diseases Issued: Thursday 4 February 2010, London UK Read the full article...
- Fda Approves Multiple Sclerosis Drug, Ampyra (dalfampridine) Extended-release
From FierceBiotech: FDA approves Acorda's new MS drug January 22, 2010 — 4:49pm ET By John Carroll [snip] The FDA announced Friday afternoon that it has approved Ampyra (dalfampridine) extended-release tablets to improve walking in patients with...
- Merck's Cladribine And Multiple Sclerosis
From FierceBiotech: Merck KGaA pulls ahead in hot oral MS drug race By John Carroll September 11, 2009 — 8:22am ET Researchers for Merck KGaA say that new analysis of the late-stage data for their oral drug cladribine highlight the drug's potential...